Wednesday, November 7, 2012

• Stocks Stay In Deep Red; Whole Foods Reports After Closeat Investor's Business Daily (Wed, Nov 7)

Tuesday, November 6, 2012

• Drug Firms Race To Reduce LDL, Novo Nordisk Awaits FDA Vote: Healthcare Business Recapat Wall St. Cheat Sheet (Tue, Nov 6)
• Here’s How Pfizer Will Get Over Lipitor Lossat Wall St. Cheat Sheet (Tue, Nov 6)
• Amgen’s Heart Drug Lowers Patient Cholesterol in Studyat Bloomberg (Tue, Nov 6)
• Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN)at TheStreet (Tue, Nov 6)

Monday, November 5, 2012

• Regeneron, Sanofi Take Step Forward With Cholesterol Drugat Minyanville (Mon, Nov 5)

Friday, November 2, 2012

• Amgen Bets on Heart Drug as Rivals Aim at Sales: Healthat Bloomberg (Fri, Nov 2)
• Vanguard Health Care Fund Does More Shedding than Adding in Third Quarterat Forbes (Fri, Nov 2)

Wednesday, October 31, 2012

• PCSK9 Inhibitor Enhances Cholesterol-Lowering Effect Of Atorvastatinat Forbes (Wed, Oct 31)

Tuesday, October 30, 2012

• Allergan Beats on EPS, Updates ViewZacks (Tue, Oct 30)
• Picking The Best Biotech Stocks, Using Intelligent Behavioral Analysisat Seeking Alpha (Tue, Oct 30)

Monday, October 29, 2012

• Strong Quarter at RegeneronZacks (Mon, Oct 29)
• Biotech Weekend Recap: Tug Of Warat Seeking Alpha (Mon, Oct 29)

Saturday, October 27, 2012

• This Week in Biotechat Motley Fool (Sat, Oct 27)
• New Developments In Lipids To Watch Closelyat Seeking Alpha (Sat, Oct 27)

Friday, October 26, 2012

• Biotech ETFs Pace Weekly Stock Decline on Earnings MissesETF Trends (Fri, Oct 26)
• Sanofi's CEO On The New York Times' Criticism Of Drug Prices And Surviving The Patent Cliffat Forbes (Fri, Oct 26)
• Identifying Opportunity, Placing Risk - Consensus Reports on Biogen Idec Inc. and Regeneron Pharmaceuticals, Inc.Marketwired (Fri, Oct 26)

Thursday, October 25, 2012

• Sirius Expected to Report Solid Q3 Ahead of Takeover and 3 Stock Analyses to See Nowat Wall St. Cheat Sheet (Thu, Oct 25)
• Eyeing a Sandbagged Guidanceat Motley Fool (Thu, Oct 25)
• Is Regeneron Pharmaceuticals Too Cautious?at Minyanville (Thu, Oct 25)
• Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN)at TheStreet (Thu, Oct 25)
• Regeneron Eylea fundamentals continue to improve, says RBC Capitaltheflyonthewall.com (Thu, Oct 25)
• Regeneron price target raised to $190 from $165 at Deutsche Banktheflyonthewall.com (Thu, Oct 25)

Wednesday, October 24, 2012

• Regeneron Pharmaceuticals CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Oct 24)

Add REGN News to My Yahoo!